CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 30,607	$ 738
Adjustments to reconcile net income to net cash provided by operating activities:
Net accretion of acquisition accounting estimates	(11,528)	(6,672)
Provision for credit losses	3,958	30,056
Depreciation and amortization	12,040	6,847
Net amortization of securities	(622)	724
Amortization of debt issuance costs	91	92
Bargain purchase gain	0	(8,816)
Gain on mortgage banking activities	(2,897)	(2,602)
Proceeds from sale of mortgage loans held for sale	117,230	80,846
Originations of loans held for sale	(131,851)	(89,485)
Stock-based compensation expense	1,252	853
Deferred income tax expense (benefit)	7,776	(934)
Losses on sales and calls of securities	0	2,166
Loss on sales of repossessed assets	375	0
(Gain) loss on valuation adjustments on mortgage servicing rights	(253)	5
Loss on disposal of fixed assets	10	0
Valuation adjustments on premises transferred to held for sale	2	271
Gain on sales and valuation adjustments on other real estate owned	0	(3)
Fair value adjustments on loans held for investments, at fair value	(246)	492
Fair value adjustment on equity securities	(124)	177
Bank owned life insurance income	(2,037)	(1,305)
Net changes in:
Accrued interest receivable	(775)	2,810
Other assets	(3,021)	(10,145)
Accrued interest payable	(1,084)	1,192
Other liabilities	(4,435)	(20,662)
Net cash provided by (used in) operating activities	14,468	(13,355)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturities and principal payments of investment securities available for sale	64,896	12,304
Proceeds from the sale of acquired AFS securities	0	434,215
Proceeds from maturities and principal payments of investment securities held to maturity	39,653	35,023
Proceeds from life insurance death benefits	150	0
Purchases of investment securities available for sale	(83,990)	0
Purchases of investment securities available for sale	(11,449)	0
Proceeds from the sale of loans held for investment	0	8,611
Purchases of equity securities	(123)	(41)
Purchase of restricted securities	(35,682)	(26,076)
Net change in loans	(84,580)	(297,999)
Purchases of premises and equipment	(3,969)	(3,654)
Proceeds from sales of other real estate owned	0	21
Proceeds from sales of repossessed assets	1,807	0
Redemption of restricted securities	33,329	28,224
Purchases of bank owned life insurance	(138)	(187)
Proceeds from disposal of premises held for sale	0	721
Cash acquired in the acquisition of TCFC, net of cash paid	0	25,372
Net cash (used in) provided by investing activities	(80,096)	216,534
Net changes in:
Noninterest-bearing deposits	313,356	(239,293)
Interest-bearing deposits	(474,828)	206,804
Short-term borrowings	0	(109,000)
Long-term borrowings	50,000	0
Common stock dividends paid	(12,013)	(8,752)
Issuance of common stock	321	272
Net cash used in financing activities	(123,164)	(149,969)
Net (decrease) increase in cash and cash equivalents	(188,792)	53,210
Cash and cash equivalents at beginning of period	372,413	55,499
Cash and cash equivalents at end of period	183,621	108,709
Supplemental cash flows information:
Interest paid	91,619	47,243
Income taxes paid	0	7,894
Recognition (remeasurement) of lease liabilities arising from right-of-use assets	25	45
Transfers from loans to repossessed assets	2,488	0
Unrealized gains (losses) on available for sale securities	2,708	(1,498)
Transfer of premises to held for sale (included in other assets)	$ 1,387	$ 750